secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pharmagreen Biotech Inc. (PHBI)
CIK:        0001435181
Form:       8-K
Filed at:   2023-05-18T23:59:59+00:00
Accession:  0001477932-23-003695
Event type: other_material
Sentiment:  neutral
Materiality: 0.40
Item codes: 4.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pharmagreen Biotech replaces auditor; Sadler, Gibb resigns, Turner Stone appointed
--------------------------------------------------------------------------------

- Sadler, Gibb & Associates resigned as auditor on April 27, 2023; no disagreements on accounting or audit scope.
- Board appointed Turner, Stone & Company as new independent registered public accounting firm effective May 4, 2023.
- No prior consultations with Turner Stone on accounting principles, transactions, or audit opinions.
- Reports for fiscal year ended Sept 30, 2022 from Sadler, Gibb contained no adverse opinion or qualification.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1435181/000147793223003695/0001477932-23-003695-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1435181/000147793223003695/phbi_8k.htm
  HTML page:      https://secwatch.observer/filing/0001477932-23-003695

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer